Needham & Company
Brian Stollar has a strong background in equity capital markets, with experience at various financial institutions. Brian currently holds the position of Head of Healthcare Equity Capital Markets at Needham & Company. Prior to this, they worked as a Managing Director in Equity Capital Markets at Oppenheimer & Co. Inc. and as a Managing Director at LifeSci Advisors, LLC. Brian also served as a Director in Healthcare Capital Markets at MLV & Co and as an Equity Sales professional at JNK Securities and Broadpoint Gleacher. Mr. Stollar has extensive experience in institutional equity sales, having worked as a Director at Cowen and Company. Earlier in their career, they held the role of Director of Business Development at UCTi Central Laboratory Services (Acquired by ICON plc) and worked as a Sales Chemist at Thermo Fisher Scientific.
Brian Stollar attended Rutgers University from 1984 to 1988, where they obtained a Bachelor of Science degree in Chemistry.
Needham & Company
1 followers
Needham Capital Partners is a private growth equity firm that invests primarily in the technology and biotech/life-sciences industries. NCP is affiliated with Needham Asset Management, which manages over $600 million in funds for public and private equity investment.